Asperger's syndrome symptoms include:
- Engaging in one-sided, long-winded conversations, without noticing if the listener is listening or trying to change the subject
- Displaying unusual nonverbal communication, such as lack of eye contact, few facial expressions, or awkward body postures and gestures
- Showing an intense obsession with one or two specific, narrow subjects, such as baseball statistics, train schedules, weather or snakes
- Appearing not to understand, empathize with or be sensitive to others' feelings
- Having a hard time "reading" other people or understanding humor
- Speaking in a voice that is monotonous, rigid or unusually fast
- Moving clumsily, with poor coordination
Unlike children with more-severe forms of autism spectrum disorders, those with Asperger's syndrome usually don't have delays in the development of language skills. That means your child will use single words by the age of 2 and phrases by the time he or she is 3 years old. But, children with Asperger's syndrome may have difficulties holding normal conversations. Conversations may feel awkward and lack the usual give and take of normal social interactions.
Toddlers and school-age children with Asperger's syndrome may not show an interest in friendships. Youngsters with Asperger's often have developmental delays in their motor skills, such as walking, catching a ball or playing on playground equipment.
In early childhood, kids with Asperger's may be quite active. By young adulthood, people with Asperger's syndrome may experience depression or anxiety.
When to see a doctor
All kids have their quirks, and many toddlers show a sign or symptom of Asperger's syndrome at some point. It's natural for small children to be egocentric, and many children show a strong interest in a particular topic, such as dinosaurs or a favorite fictional character. These generally aren't reasons to be alarmed.
However, if your elementary schoolchild has frequent problems in school or seems unable to make friends, it's time to talk with your child's doctor. These difficulties have many possible causes, but developmental disorders such as Asperger's syndrome need to be considered. Children who have behaviors that interfere with learning and social development should have a comprehensive evaluation.
Nov. 18, 2010
- Asperger's disorder. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. Arlington, Va.: American Psychiatric Association; 2000. http://psychiatryonline.com/content.aspx?aID=7667&searchStr=asperger%27s+disorder. Accessed Sept. 10, 2010.
- Toth K, et al. Asperger's syndrome: Diagnosis and treatment. American Journal of Psychiatry. 2008;165:958.
- Autism spectrum disorders. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec19/ch299/ch299c.html#S19_CH299_T002. Accessed Sept. 11, 2010.
- Asperger syndrome fact sheet. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/asperger/detail_asperger.htm?css=print. Accessed Sept 11, 2010.
- Notordaeme M, et al. Asperger's syndrome and high-functioning autism: Language, motor and cognitive profiles. European Child and Adolescent Psychiatry. 2010;19:475.
- Asperger syndrome. National Institute of Child Health and Human Development. http://www.nichd.nih.gov/health/topics/asperger_syndrome.cfm. Accessed Sept. 11, 2010.
- Weber K. Asperger's syndrome: From hiding to thriving. The Nurse Practitioner. 2008;19:14.
- Levy SE, et al. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatry Clinics of North America. 2008;17:803.
- Price CS, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126:656.
- Atkinson DL (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 25, 2010.
- Stigler KA, et al. Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: A 14-week, perspective, open-label study. Journal of Child and Adolescent Psychopharmacology. 2009;19:265.
- Posey DJ, et al. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: A retrospective analysis of 80 cases. Journal of Child and Adolescent Psychopharmacology. 2004;14:233.
- Moreno C, et al. Metabolic effects of second-generation antipsychotics in bipolar youth: Comparison with other psychotic and nonpsychotic diagnoses. Bipolar Disorders. 2010;12:172.
- Malone RP, et al. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drugs. 2005;19:923.
- Elchaar GM, et al. Efficacy and safety of naltrexone use in pediatric patients with autistic disorder. Annals of Pharmacotherapy. 2006;40:1086.
- Questions and answers on unapproved chelation products. Food and Drug Administration. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/ucm229313.htm. Accessed Oct. 26, 2010.
- Guastella AJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry. 2010;67:692.
- Hollander E, et al. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 2007;61:498.
You Are ... The Campaign for Mayo Clinic
Mayo Clinic is a not-for-profit organization. Make a difference today.